| 1/4 | US=22 / Câncer Copur MS, Rose M, Gettinger SN. Miscellaneous chemotherapeutic agents. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 490-5. AGENTES QUIMIOTERAPICOS; BLEOMYCIN; PROCARBAZINE; THALIDOMIDE; LENALIDOMIDE |
| 2/4 | US=64 / Câncer Yhomas SK, Richards TA, Weber DM. Lenalidomide in relapsed or refractory multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 265-77. (Comtemporary Hematology) ISBN 978-1-934115-82-4. LENALIDOMIDA EM RECIDIVA; MIELOMA MULTIPLO REFRACTARIO; ESTEROIDES; ANTRACICLINAS |
| 3/4 | US=64 / Câncer Kumar S. Lenalidomide for initial therapy of newly diagnosed multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 279-88. (Comtemporary Hematology) ISBN 978-1-934115-82-4. LENALIDOMIDA. TERAPIA COM MIELOMA MULTIPLO; MALIGNIDADE HEMATOLOGICA. LINFOMA NAO-HODGKIN |
| 4/4 | Câncer Rodríguez MRL, Combariza J, Casas CP, Reveiz L, Buendía J, Carvajal AM, Ramírez HB, Cardona AF. First line therapy for patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplantation: a systematic review and meta-analysis (hemo-oncolgroup study). Applied Cancer Research, São Paulo: Tecmedd, v.32, n.4, p. 122-41, 2012. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(4)p.122-41.pdf QUIMIOTERAPIA; META-ANALISES; MIELOMA MULTIPLO; TRANSPLANTE AUTOLOGO |